Cargando…
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
CAPTURE (NCT03226886) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated 585 patients following administration of two doses of BNT162b2 or AZD1222 vaccines, administered 12 weeks apart. Seroconversion rates after two doses were 85% and 59% in patients with...
Ejemplares similares
-
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
por: Fendler, Annika, et al.
Publicado: (2021) -
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer
por: Fendler, Annika, et al.
Publicado: (2022) -
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
por: Fendler, Annika, et al.
Publicado: (2022) -
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
por: Fendler, Annika, et al.
Publicado: (2022) -
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
por: Fendler, Annika, et al.
Publicado: (2022)